Lotus Eye Hospital & Institute
LOTUSEYENSE

Lotus Eye Hospital & Institute

₹108.370.19 (0.18%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
107.96
Today’s high
109.90
52 week low
67.72
52 week high
147.00
Open price
108.00
Previous close
108.18
Live volume
9,645
Lower circuit
97.37
Upper circuit
118.99

Fundamentals

Market Cap
₹225Cr
ROE
0.13%
P/E Ratio(TTM)
2705.00
EPS(TTM)
0.04
P/B Ratio
3.74
Dividend Yield
0.00%
Industry P/E
78.44
Book Value
28.92
Debt to Equity
0.26
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹14.09
+2.18%
Profit (Cr)
-₹0.32
-23.08%
-4-25 L02.259
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+17%
3Y CAGR+9%
Profit growthValue
3Y CAGR-37%

About

Lotus Eye Hospital is a high-tech super specialty institution known for its excellence in Ophthalmic service with personalized care. The company's vision is to become the world's leading eye care provider by ensuring it has happy and satisfied patients and stakeholders. Its primary mission is to be a center of excellence in India by providing the highest level of quality eye care with skill and concern. The hospital operates nine specialized Eye Care centers across the states of Tamil Nadu and Kerala, expanding its reach to more communities. A key part of its strategy is adopting the latest technologies, techniques, and ethical practices in the field of ophthalmology. During the 2023-24 financial year, the company increased its turnover to 48.21 crores, up from 47.04 crores in the previous year.;
CEO/MD
Dr. K.S. Ramalingam
Founded in
1997
NSE symbol
LOTUSEYE

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
59.84%
Promoters
40.14%
Other Domestic Institutions
0.02%
2026
26
May
Quarterly & Annual Result
Release date
11
Feb
Quarterly Result
Release date
2025
12
Nov
Quarterly Result
Release date
12
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks